Cipla gains with arm entering into agreement to sell 99% stake in AJDMA

09 Jun 2017 Evaluate

Cipla is currently trading at Rs. 553.00, up by 4.05 points or 0.74% from its previous closing of Rs. 548.95 on the BSE.

The scrip opened at Rs. 550.00 and has touched a high and low of Rs. 555.05 and Rs. 550.00 respectively. So far 11,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 621.90 on 06-Feb-2017 and a 52 week low of Rs. 460.00 on 24-Jun-2016.

Last one week high and low of the scrip stood at Rs. 555.05 and Rs. 523.00 respectively. The current market cap of the company is Rs. 44,455.00 crore.

The promoters holding in the company stood at 37.48%, while Institutions and Non-Institutions held 36.05% and 26.47% respectively.

Cipla’s subsidiary - Saba Investment has entered into an agreement to sell its entire 99% equity stake in Al Jabal for Drugs and Medical Appliances Company, Yemen (AJDMA) to Khalil Ghaleb Ali Al-Jabal. The company has entered into an agreement for sale on June 7, 2017 and the transaction is expected to be closed within 35 days from Effective Date.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries.


Cipla Share Price

1375.20 -6.05 (-0.44%)
16-Apr-2024 15:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1537.90
Dr. Reddys Lab 6050.55
Cipla 1375.20
Zydus Lifesciences 945.15
Lupin 1611.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.